Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether choline supplementation can improve cognitive functioning of children with prenatal alcohol exposure.

Clinical Trial Description

Despite the known damaging effects of alcohol on the developing fetus and the presence of warning labels on alcoholic beverages, many pregnant women continue to drink alcohol. The consequences include a range of physical, neurological, and behavioral effects referred to as fetal alcohol spectrum disorders (FASD). Unfortunately, there are currently no comprehensive treatments for individuals with FASD. This pilot study will examine whether a nutritional intervention could reduce the severity of cognitive deficits associated with prenatal alcohol exposure. Choline is an essential nutrient, necessary for brain and behavioral development. Animal studies have shown that prenatal or early postnatal choline supplementation can lead to long-lasting cognitive enhancement. Similarly, choline supplementation improves cognitive outcomes among rats exposed to alcohol during development, even when administered postnatally and after alcohol exposure has occurred. The present experiment translates these findings to a clinical population of individuals exposed to heavy prenatal alcohol exposure. Subjects will be randomly assigned to receive daily choline supplementation or placebo control for a period of 6 weeks (approximately 20 subjects per group). Performance on neuropsychological tasks that measure cognitive functioning will be measured prior to treatment and at 6 weeks. These data will provide important information regarding a potential nutritional intervention for fetal alcohol spectrum disorders. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Alcohol-related Neurodevelopmental Disorder
Disease
Fetal Alcohol Spectrum Disorders
Fetal Alcohol Syndrome
Mental Disorders Diagnosed in Childhood
Partial Fetal Alcohol Syndrome
Prenatal Alcohol Exposure
Syndrome

Clinical Trial Details

NCT number	NCT01911299
Study type	Interventional
Source	San Diego State University
Contact
Status	Completed
Phase	Phase 2
Start date	May 2013
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06163651` - Evaluating a One-Year Version of the Parent-Child Assistance Program	N/A
Completed	`NCT01961050` - Preventing FAS/ARND in Russian Children	N/A
Recruiting	`NCT05108974` - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study	Phase 2
Completed	`NCT02457676` - Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention	N/A
Recruiting	`NCT06005181` - The Synchrony Study: Examining Music Training for Children With FASD	N/A
Completed	`NCT04571463` - Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
Completed	`NCT03361293` - Cognitive Training and tDCS for Children With FASD	N/A
Recruiting	`NCT05534568` - The Oklahoma Parent-Child Assistance Program	N/A
Recruiting	`NCT05456321` - CIFASD 5 tDCS and Cognitive Training	N/A
Recruiting	`NCT04332172` - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy	N/A
Recruiting	`NCT05960461` - Families Moving Forward (FMF) Connect Pro for Mental Health Providers	N/A
Completed	`NCT05604014` - Feasibility Study of the My Health Coach App for Adults With FASD	N/A
Terminated	`NCT03852550` - READYorNot[TM] Brain-Based Disabilities Trial	N/A
Completed	`NCT02735473` - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders	Phase 2
Completed	`NCT03782935` - Nutritional Risk Factors for FASD in Ukraine	N/A
Not yet recruiting	`NCT04918043` - Alcohol Use During Pregnancy in Finland According to Meconium Samples
Completed	`NCT04072809` - Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
Completed	`NCT01149538` - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure	Phase 1/Phase 2
Completed	`NCT05028517` - Efficacy Trial of the FMF Connect Mobile Health Intervention	N/A
Completed	`NCT04194489` - Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.